AG007C6D

108612-45-9 | 2-[[1-[1-[(4-Fluorophenyl)methyl]-1H-benzimidazol-2-yl]-4-piperidinyl]methylamino]-4(3H)-pyrimidinone

Chemical structure of 2-[[1-[1-[(4-Fluorophenyl)methyl]-1H-benzimidazol-2-yl]-4-piperidinyl]methylamino]-4(3H)-pyrimidinone, CAS 108612-45-9
AG007C6D
sdsSDS
sdsCOA
TIP This product is typically in stock.Please contact us for quotation.
Request For Quotation

CAS Number 108612-45-9
Catalog Number AG007C6D(AGN-PC-0OYP3N)
Chemical Name 2-[[1-[1-[(4-Fluorophenyl)methyl]-1H-benzimidazol-2-yl]-4-piperidinyl]methylamino]-4(3H)-pyrimidinone
IUPAC Name 2-[[1-[1-[(4-fluorophenyl)methyl]benzimidazol-2-yl]piperidin-4-yl]-methylamino]-1H-pyrimidin-6-one
InChI InChI=1S/C24H25FN6O/c1-29(23-26-13-10-22(32)28-23)19-11-14-30(15-12-19)24-27-20-4-2-3-5-21(20)31(24)16-17-6-8-18(25)9-7-17/h2-10,13,19H,11-12,14-16H2,1H3,(H,26,28,32)
InChI Key PVLJETXTTWAYEW-UHFFFAOYSA-N
MDL Number MFCD00864625
Molecular Formula C24H25FN6O
Molecular Weight 432.4933
SMILES C(n1c(nc2c1cccc2)N1CCC(CC1)N(C)c1[nH]c(=O)ccn1)c1ccc(cc1)F
UNII 244O1F90NA
Synonyms
Mistalin, Mistamine, mizolastine, Mizolen, Mizollen, SL 85.0324, SL-85.0324, Zolim, Zolistan, Mizolastine, 108612-45-9, Mizollen, Mistamine, Zolistan, SL 85.0324, Mizolastinum [INN-Latin], Mizolastina [INN-Spanish], SL-85.0324, UNII-244O1F90NA, C24H25FN6O, Mizolastine (Mizollen), MKC-431, CHEMBL94454, Mistalin, 244O1F90NA, 2-((1-(1-(p-Fluorobenzyl)-2-benzimidazolyl)-4-piperidyl)methylamino)-4(3H)-pyrimidinone, NCGC00181013-01, Mizolastina, Mizolastinum, Mizolen, Zolim, SL 850324, DSSTox_CID_26801, DSSTox_RID_81916, DSSTox_GSID_46801, 2-((1-(1-(4-fluorobenzyl)-1H-benzo[d]imidazol-2-yl)piperidin-4-yl)(methyl)amino)pyrimidin-4(3H)-one, 2-[[1-[1-[(4-fluorophenyl)methyl]benzimidazol-2-yl]piperidin-4-yl]-methylamino]-1H-pyrimidin-6-one, 2-[[1-[1-[(4-Fluorophenyl)methyl]benzoimidazol-2-yl]-4-piperidyl]-methyl-amino]-3H-pyrimidin-4-one, Mizolastine [INN], Zolistam, 2-{1-[1-(4-Fluorobenzyl)-1H-benzimidazol-2-yl]-4-piperidyl(methyl)amino}pyrimidin-4(1H)-one, Mizollen (TN), 2-[[1-[1-[(4-Fluorophenyl)methyl]-1H-benzimidazol-2-yl]-4-piperidinyl]methylamino]-4(1H)-pyrimidinone, 4(1H)-Pyrimidinone, 2-((1-(1-((4-fluorophenyl)methyl)-1H-benzimidazol-2-yl)-4-piperidinyl)methylamino)-, CAS-108612-45-9, Mizolastine (JAN/INN), Mizolastine [INN:BAN], CCRIS 8410, mizolastine-mizollen, SCHEMBL5061, MLS006010068, AC1L247Z, MKC431, DTXSID5046801, BDBM22877, CHEBI:31857, CTK8B8764, GTPL10102, MKC 431, PVLJETXTTWAYEW-UHFFFAOYSA-N, HMS3713N04, HY-B0164, KS-00001F6Q, Tox21_112663, AC-634, AN-810, ANW-61207, MFCD00864625, ZINC13831810, AKOS005145756, AKOS016003409, Tox21_112663_1, API0003411, CCG-220621, CS-1997, DB12523, KS-1139, RL00370, NCGC00344565-01, NCGC00344565-04, BC209165, CC-30974, I520, SC-17003, SL850324, SMR003965484, AB0013741, AB2000511, LS-135935, SL-850324, FT-0628955, M2756, A11724, D01117, J10320, 54336-EP2270008A1, 54336-EP2292617A1, 54336-EP2292619A1, 54336-EP2305640A2, 54336-EP2305659A1, 54336-EP2308562A2, 54336-EP2371811A2, AB01566892_01, 612M459, A801901, C-22266, I06-0373, J-507624, BRD-K21884483-001-01-1, 2-((1-(1-(4-Fluorobenzyl)-1H-benzo[d]imidazol-2-yl)-piperidin-4-yl)(methyl)amino)pyrimidin-4(1H)-one, 2-({1-[1-(4-Fluoro-benzyl)-1H-benzoimidazol-2-yl]-piperidin-4-yl}-methyl-amino)-3H-pyrimidin-4-one, 2-({1-[1-(4-fluorobenzyl)-1H-benzimidazol-2-yl]-piperidin-4-yl}-methylamino)-4(1H) pyrimidinone, 2-[(1-{1-[(4-fluorophenyl)methyl]-1H-1,3-benzodiazol-2-yl}piperidin-4-yl)(methyl)amino]-3,4-dihydropyrimidin-4-one, 2-[[1-[1-[(4-Fluorophenyl)methyl]-1H-benzimidazol-2-yl]-4-piperidinyl]methylamino]- 4(1H)-pyrimidinone, 2-[[1-[1-[(4-fluorophenyl)methyl]-2-benzimidazolyl]-4-piperidinyl]-methylamino]-1H-pyrimidin-6-one, 2-[[1-[1-[(4-fluorophenyl)methyl]benzimidazol-2-yl]-4-piperidyl]-methyl-amino]-1H-pyrimidin-6-one, 2-[[1-[1-[(4-fluorophenyl)methyl]benzimidazol-2-yl]piperidin-4-yl]-methyl-amino]-1H-pyrimidin-6-one, Novag brand of mizolastine, D06MAJ, Allphar brand of mizolastine, Schwarz brand of mizolastine, Galderma brand of mizolastine, Mizolastine, 98% - 1G 1g, 2-(Dicyclohexylphosphino)biphenyl, CID65906, C24-H25-F-N6-O, Sanofi Synthelabo brand of mizolastine, B1551, S2107, C076170, 2-((1-(1-(4-Fluorobenzyl)-1H-benzo[d]imidazol-2-yl)piperidin-4-yl)(methyl)amino)pyrimidin-4(1H)-one, 2-[[1-[1-(p-fluorobenzyl)-2-benzimidazolyl]-4-piperidinyl]methylamino]-4(3H)-pyrimidinone, 2-({1-[3-(4-Fluoro-benzyl)-1H-benzoimidazol-2-yl]-piperidin-4-yl}-methyl-amino)-2,3-dihydro-1H-pyrimidin-4-one(Mizolastine),

Related Research Chemicals

CERTIFICATE OF ANALYSIS
Chemical Name: Batch Number:
Chemical Structure: CAS Registry No:
Product ID:
Manufacture Date:
Storage Temperature:
Formula:
Molecular Weight:
Quantity:
Analysis Data:
Test: Result:
Conclusion: The above product meets the specifications of Angene.
Analyst:Chase
Date:
Reviewed by:Jessie
Date:
Angene International Limited